These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 23535565

  • 1. Antithrombotic activity of HY023016, a novel Dabigatran prodrug evaluated in animal thrombosis models.
    Li YZ, Gong GQ, Yang WH, Wang XH, Jiang ML, Zhou Y, Yang XZ, Xu YG, He GW.
    Thromb Res; 2013 May; 131(5):425-35. PubMed ID: 23535565
    [Abstract] [Full Text] [Related]

  • 2. Evaluating antithrombotic activity of HY023016 on rat hypercoagulable model.
    Chen QF, Li YZ, Wang XH, Su YR, Cui S, Miao MX, Jiang ZZ, Jiang ML, Jiang AD, Chen X, Xu YG, Gong GQ.
    Eur J Pharmacol; 2016 Jun 15; 781():190-7. PubMed ID: 27085896
    [Abstract] [Full Text] [Related]

  • 3. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
    Wienen W, Stassen JM, Priepke H, Ries UJ, Hauel N.
    Thromb Haemost; 2007 Jul 15; 98(1):155-62. PubMed ID: 17598008
    [Abstract] [Full Text] [Related]

  • 4. Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on thrombus formation and bleeding time in rats.
    Wienen W, Stassen JM, Priepke H, Ries UJ, Hauel N.
    Thromb Haemost; 2007 Aug 15; 98(2):333-8. PubMed ID: 17721615
    [Abstract] [Full Text] [Related]

  • 5. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.
    Stangier J, Rathgen K, Stähle H, Gansser D, Roth W.
    Br J Clin Pharmacol; 2007 Sep 15; 64(3):292-303. PubMed ID: 17506785
    [Abstract] [Full Text] [Related]

  • 6. The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples.
    Hapgood G, Butler J, Malan E, Chunilal S, Tran H.
    Thromb Haemost; 2013 Aug 15; 110(2):308-15. PubMed ID: 23783268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis.
    Wienen W, Stassen JM, Priepke H, Ries UJ, Hauel N.
    J Thromb Haemost; 2007 Jun 15; 5(6):1237-42. PubMed ID: 17362226
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits.
    Yau JW, Liao P, Fredenburgh JC, Roberts RS, Weitz JI.
    Thromb Haemost; 2014 Jul 03; 112(1):79-86. PubMed ID: 24573541
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, with coadministration of digoxin.
    Stangier J, Stähle H, Rathgen K, Roth W, Reseski K, Körnicke T.
    J Clin Pharmacol; 2012 Feb 03; 52(2):243-50. PubMed ID: 21868715
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.